Development of medicinal products for the treatment of post-traumatic stress disorder

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/358650/2006 Corr. 2
Published24/07/2008
Effective from01/02/2009
KeywordsPost-traumatic stress disorder (PTSD), anxiety disorder
DescriptionThis document provides guidance on the planning of clinical studies concerning the treatment of post-traumatic stress disorder.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/02/2009–present


Published: 24/07/2008


Published: 20/09/2007


Published: 21/09/2006


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more